OD
The startup has developed a peptide identification and optimization platform that utilizes peptide bead display and ribonucleic acid display technologies to discover and present novel natural peptides. This platform enables clients to efficiently identify therapeutic candidates through high-throughput affinity and functional screening, addressing the need for biologically relevant peptide leads in drug development.
Updated 3 months ago
Funding
$17.2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup has developed a peptide identification and optimization platform that utilizes peptide bead display and ribonucleic acid display technologies to discover and present novel natural peptides. This platform enables clients to efficiently identify therapeutic candidates through high-throughput affinity and functional screening, addressing the need for biologically relevant peptide leads in drug development.